GSK shares surge after reaching settlement on Zantac ahead of California trial
GSK GSK, +5.45% shares surged 6% in London action as the U.K. pharmaceutical said it reached a settlement over its Zantac heartburn medication litigation with a plaintiff in…
Read more GSK shares surge after reaching settlement on Zantac ahead of California trial